Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-001766
Filing Date
2025-12-19
Accepted
2025-12-19 17:21:54
Documents
1
Period of Report
2025-12-17

Document Format Files

Seq Description Document Type Size
1 e665060_4-chivukula.html 4  
1 e665060_4-chivukula.xml 4 4356
  Complete submission text file 0001193805-25-001766.txt   5741
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Chivukula Pad (Reporting) CIK: 0001727317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 251588590

Mailing Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA
Business Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)